Avelumab, a PD‐L1 Inhibitor, in Combination with Hypofractionated Radiotherapy and the Abscopal Effect in Relapsed Refractory Multiple Myeloma

por Kazandjian, Dickran, Dew, Alexander, Hill, Elizabeth, Ramirez, Elizabeth Gil, Morrison, Candis, Mena, Esther, Lindenberg, Liza, Yuan, Constance, Maric, Irina, Wang, Hao‐Wei, Calvo, Katherine, Dulau‐Florea, Alina, Roswarski, Joseph, Emanuel, Michael, Braylan, Raul, Turkbey, Baris, Choyke, Peter, Camphausen, Kevin, Stetler‐Stevenson, Maryalice, Steinberg, Seth M., Figg, William D., C. Jones, Jennifer
Publicado 2021